Qianting Zhai

Title: Qianting Zhai: Innovator in Cancer Treatment

Introduction

Qianting Zhai is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 3 patents, Zhai's work focuses on developing advanced therapeutic methods and compositions.

Latest Patents

One of his latest patents is titled "Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto." This invention provides multi-specific antibodies that target both a cellular efflux pump and a cancer-associated antigen. It also includes pharmaceutical compositions, nucleic acids, recombinant expression vectors, cells, and kits that incorporate or encode these multi-specific antibodies. Additionally, the patent outlines methods for treating cancer by administering these antibodies to patients. Another significant patent is for "Anti-hypusine antibodies and uses thereof." This invention offers anti-hypusine antibodies that are useful in detecting and isolating polypeptides containing hypusine and/or deoxyhypusine, along with related compositions and kits.

Career Highlights

Qianting Zhai has worked with prominent organizations, including Genentech, Inc. and the William Robert Arathoon Living Trust Dated August 29, 2016. His experience in these companies has contributed to his expertise in the field of biotechnology and cancer research.

Collaborations

Zhai has collaborated with notable individuals such as Paul J Carter and William Robert Arathoon. These partnerships have likely enhanced his research and development efforts in creating innovative solutions for cancer treatment.

Conclusion

Qianting Zhai's contributions to cancer treatment through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to pave the way for advancements in therapeutic methods and compositions.